NPI: 1871862730 · PATERSON, NJ 07503 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/22/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 12/22/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 43,885 | $2.71M |
| 2019 | 45,720 | $3.18M |
| 2020 | 40,525 | $2.16M |
| 2021 | 31,745 | $1.62M |
| 2022 | 46,846 | $1.40M |
| 2023 | 19,362 | $1.02M |
| 2024 | 12,519 | $760K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 94,533 | 7,326 | $11.21M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 47,507 | 3,468 | $862K |
| J1270 | Injection, doxercalciferol, 1 mcg | 36,002 | 3,016 | $279K |
| J1756 | Injection, iron sucrose, 1 mg | 14,050 | 2,974 | $117K |
| 90945 | 2,278 | 97 | $75K | |
| A4657 | Syringe, with or without needle, each | 22,505 | 4,493 | $57K |
| 85048 | 2,731 | 2,198 | $41K | |
| 85041 | 2,752 | 2,210 | $41K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 537 | 339 | $33K |
| 83970 | 2,231 | 1,706 | $27K | |
| 83540 | 1,717 | 1,432 | $25K | |
| 83550 | 1,509 | 1,346 | $25K | |
| 82728 | 1,697 | 1,443 | $24K | |
| 85046 | 549 | 542 | $23K | |
| 82947 | 94 | 92 | $5K | |
| 90674 | 166 | 150 | $3K | |
| G0008 | Administration of influenza virus vaccine | 397 | 340 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 57 | 56 | $2K |
| 90662 | 181 | 136 | $617.68 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,368 | 571 | $214.45 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,663 | 927 | $128.14 |
| 90677 | 13 | 13 | $60.10 | |
| 90661 | 15 | 15 | $36.85 | |
| G0009 | Administration of pneumococcal vaccine | 14 | 13 | $13.36 |
| OP250 | 6,036 | 327 | $0.00 |